These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27788588)

  • 1. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus.
    Abdel Wahab AHA; El-Halawany MS; Emam AA; Elfiky A; Abd Elmageed ZY
    Biomarkers; 2017 Nov; 22(7):621-628. PubMed ID: 27788588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
    El-Mesery M; El-Mowafy M; Elgaml A; Youssef LF; Abed SY
    J Interferon Cytokine Res; 2017 Aug; 37(8):342-347. PubMed ID: 28609212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
    Nabih MI; Aref WM; Fathy MM
    Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis.
    Ferrín G; Rodríguez-Perálvarez M; Aguilar-Melero P; Ranchal I; Llamoza C; Linares CI; González-Rubio S; Muntané J; Briceño J; López-Cillero P; Montero-Álvarez JL; de la Mata M
    PLoS One; 2015; 10(3):e0118527. PubMed ID: 25789864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma.
    Fouad YM; Mohamed HI; Kamal EM; Rasek MA
    Scand J Gastroenterol; 2016 Sep; 51(9):1133-7. PubMed ID: 27161933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Chen DS; Yu CY; Wen CL; Lu FJ; Chow LP
    Proteomics; 2006 May; 6(9):2865-73. PubMed ID: 16586433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
    Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
    Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
    Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
    Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
    El-Shal AS; Zidan HE; Rashad NM; Wadea FM
    Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.